In a filing, BridgeBio Pharma Inc revealed its Chief Executive Officer Kumar Neil unloaded Company’s shares for reported $2.24 million on Dec 15 ’25. In the deal valued at $74.64 per share,30,011 shares were sold. As a result of this transaction, Kumar Neil now holds 228,776 shares worth roughly $17.64 million.
Then, NEIL KUMAR bought 30,011 shares, generating $2,255,327 in total proceeds.
Before that, Apuli Maricel sold 2,000 shares. BridgeBio Pharma Inc shares valued at $148,520 were divested by the Chief Accounting Officer at a price of $74.26 per share. As a result of the transaction, Apuli Maricel now holds 130,297 shares, worth roughly $10.04 million.
Bernstein initiated its BridgeBio Pharma Inc [BBIO] rating to an Outperform in a research note published on December 11, 2025; the price target was $94. Truist began covering BBIO with “Buy” recommendation on July 21, 2025. Jefferies started covering the stock on July 14, 2025. It rated BBIO as “a Buy”.
Price Performance Review of BBIO
On Monday, BridgeBio Pharma Inc [NASDAQ:BBIO] saw its stock jump 1.04% to $77.09. Over the last five days, the stock has gained 3.46%. BridgeBio Pharma Inc shares have risen nearly 196.73% since the year began. Nevertheless, the stocks have risen 180.94% over the past one year. While a 52-week high of $77.20 was reached on 12/22/25, a 52-week low of $26.02 was recorded on 01/02/25.
Levels Of Support And Resistance For BBIO Stock
The 24-hour chart illustrates a support level at 76.21, which if violated will result in even more drops to 75.34. On the upside, there is a resistance level at 78.20. A further resistance level may holdings at 79.32.
How much short interest is there in BridgeBio Pharma Inc?
A steep rise in short interest was recorded in BridgeBio Pharma Inc stocks on 2025-11-28, dropping by -0.18 million shares to a total of 19.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 19.57 million shares. There was a decline of -0.95%, which implies that there is a negative sentiment for the stock.
